effect overlay
activetrials
Multiple Sclerosis

Biomarkers of motor performance in multiple sclerosis: 7T MRI study
 

HREC: 2015.144
Principal Investigator: Prof Trevor Kilpatrick
Coordinator contact: Dr Vivien Li
Funding: Non-Commercial
Multiple Sclerosis

A prospective, multicenter, observational, post-authorization safety study (PASS) to evaluate the long term safety profile of LEMTRADA® (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosis
 

HREC: 2015.153
Principal Investigator: Dr Mark Marriott
Coordinator contact: Lisa Taylor
Funding: Commercial
Multiple Sclerosis

Prospective clinic and home-based serial monitoring of cognition in relapsing- remitting multiple sclerosis
 

HREC: 2015.174
Principal Investigator: Prof Tomas Kalincik
Coordinator contact: Dr Anneke van der Walt
Funding: Non-Commercial

Retrospective analyses of clinically acquired MRI in multiple sclerosis
 

HREC: 2017.118
Principal Investigator: Prof Helmut Butzkueven
Coordinator contact: Dr Ai-Lan Nguyen
Funding: Non-Commercial
Multiple Sclerosis

Assessment of whether Cladribine reconfigures mononuclear cells to a reparative M2-like phenotype
 

HREC: 2018.197
Principal Investigator: Prof Trevor Kilpatrick
Coordinator contact: Katherine Fazzolari
Funding: Non-Commercial